Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
about
Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor AgonistsA clinical review of GLP-1 receptor agonists: efficacy and safety in diabetes and beyondThe Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic ReviewThe burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg.The Predictive Role of Tooth Extractions, Oral Infections, and hs-C-Reactive Protein for Mortality in Individuals with and without Diabetes: A Prospective Cohort Study of a 12 1/2-Year Follow-UpLong-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study.Factors associated with no apparent coronary artery disease in patients with type 2 diabetes mellitus for more than 10 years of duration: a case control study.Cardiometabolic Effects of Glucagon-Like Peptide-1 Agonists.The emerging role of metformin in gestational diabetes mellitus.Association Between Subtotal Gastrectomy with Billroth II Anastomosis and Coronary Heart Disease.The Role of the Pharmacist in Managing Type 2 Diabetes with Glucagon-Like Peptide-1 Receptor Agonists as Add-On Therapy.Adverse effects of incretin-based therapies on major cardiovascular and arrhythmia events: meta-analysis of randomized trials.Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats.Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study.A Review on the Phytochemistry, Pharmacology, Pharmacokinetics and Toxicology of Geniposide, a Natural Product.Liraglutide mitigates TNF-α induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women.Efficacy and Safety of Ranolazine in Diabetic Patients: A Systematic Review and Meta-analysis.Comparative Cardiovascular Risks of Dipeptidyl Peptidase-4 Inhibitors: Analyses of Real-world Data in Korea.Long-Acting GLP-1 Receptor Agonist Exenatide Influence on the Autonomic Cardiac Sympatho-Vagal Balance.Chemistry and Hypoglycemic Activity of GPR119 Agonist ZB-16
P2860
Q26749495-79368BC6-8CE6-4E37-B528-DC591A9B5F75Q26799389-27B089B1-D4B4-4F4A-A6F9-86EA66119167Q28078225-EA6FD90B-8C26-4CEB-9388-CACAFA077024Q33750634-9E76EC9C-B635-4414-AD21-CF898FA2491EQ33872769-584DAD74-44BC-4600-A7C5-CF81F0BE7D0EQ36023385-65F4FA63-B830-4568-A6D8-E7BEA58CE601Q36235047-A27170EE-C78B-4608-ADF3-BAC5DC5D2DE4Q38702260-A4DF8069-D6A9-4A00-9C38-47BA9F769B1DQ38996030-303C44D5-79EC-4C9F-BBB8-B37B1D15F8DEQ39025644-9384CFF0-6448-4B7C-9BD9-953923F48CA4Q39140294-53FE3D60-4463-426C-BCF9-29374687CEF9Q39870068-EBE805C2-61F9-4A3C-B3E9-E9FEC1A4767AQ41811427-802D9C01-D466-4DBA-98B8-5B5CDF7C22BEQ42319765-278D4633-3422-46FC-8C9D-18AB0D6893BDQ46289886-F459615F-1A2D-4FAC-A307-A4B4F2EB7B29Q48329387-225EFB20-C3D1-4568-8C0E-3A9E96DAC6BEQ49909252-E1371AFE-2B7F-465D-B9C5-C2A4F5738947Q54993721-DEDE105C-945B-402B-9CC4-CD2A27DCB71CQ55090958-925A243A-0026-4769-AD00-5902C8B2F4EEQ57072608-E227D3D2-8F63-4327-AE3F-0201748EE3B5
P2860
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@ast
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@en
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@nl
type
label
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@ast
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@en
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@nl
prefLabel
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@ast
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@en
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@nl
P2860
P921
P3181
P1476
Cardiovascular effects of glucagon-like peptide 1 (GLP-1) receptor agonists
@en
P2093
Francisco Kerr Saraiva
P2860
P2888
P3181
P356
10.1186/S12933-014-0142-7
P407
P5008
P577
2014-10-22T00:00:00Z
P5875
P6179
1032376861